US Patent 8106163 Compositions and methods of use for therapeutic antibodies
Patent 8106163 was granted and assigned to Novartis on January, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 7 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 1 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+509 characters)
Article
Patent abstract
The present invention relates to antibodies that specifically bind to the BAFF receptor (BAFFR). The invention more specifically relates to specific antibodies that are BAFFR antagonists with in vivo B cell depleting activity and compositions and methods of use for said antibodies to treat pathological disorders that can be treated by killing or depleting B cells, such as systemic lupus erythematosus or rheumatoid arthritis or other autoimmune diseases or lymphomas, leukemias and myelomas.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08106163 Compositions and methods of use for therapeutic antibodies US Patent 8106163 Compositions and methods of use for therapeutic antibodies
Infobox
Patent Number
0810616300
Patent Number
810616300
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081061630
Date of Patent
January 31, 2012
0Patent Application Number
125031750
Date Filed
July 15, 2009
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081061630
Date of Patent
January 31, 2012
0Patent Application Number
125031750
Date Filed
July 15, 2009
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08106163 Compositions and methods of use for therapeutic antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08106163
Date of patent
January 31, 2012
Patent application number
12503175
Date Filed
July 15, 2009
Patent primary examiner
Find more entities like US Patent 8106163 Compositions and methods of use for therapeutic antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.